Kenneth Custer

Kenneth Custer

executiveMale0.0Global Dominance: 0.00%

Kenneth Custer is the president of Eli Lilly, a leading American pharmaceutical company known for its innovative treatments. Under his leadership, the company is advancing its research and development initiatives, including a new oral weight-loss medication called orforglipron, which has shown promising results in a recent clinical trial for obesity management. Custer emphasizes the potential of this daily pill to transform obesity care by offering a convenient alternative to existing injectable treatments.

Power0
Reach0
Collect

Not in the pool (under ¢1).

Recent news mentions

Kenneth Custer, president of Lilly Cardiometabolic Health, said the company is encouraged by the results of the trial as it highlights 'the powerful effect of retatrutide' on body weight, pain and physical function.

Eli Lilly drug delivers strong weight loss and arthritis pain relief results
Fox News·United StatesUnited States· 2025-12-11
7.0
Also mentioned
Marc Siegel
Marc Siegel

Eli Lilly vice president Kenneth Custer stated that they are quickly moving forward with market approvals based on positive data.

uus tablett jätab süstid ajalukku
Postimees – major Estonian daily, est. 1857·EstoniaEstonia· 2025-12-01
8.0

Dr. Kenneth Custer, representative of Eli Lilly, stated that the company intends to submit the licensing application before the end of the year.

Noua pastilă zilnică care promite să te ajute să slăbești 12% din greutate – o revoluție în lupta cu obezitatea
Adevărul·RomaniaRomania· 2025-08-09
7.0

Kenneth Custer from Eli Lilly stated that they are working to transform obesity care with a potential oral therapy.

O pastilă revoluționară pentru slăbit schimbă lupta împotriva obezității. Pacienții pierd până la 12 kilograme în câteva săptămâni
Adevărul·RomaniaRomania· 2025-08-08
8.0

Dr Kenneth Custer of Eli Lilly said the company was planning to submit the drug for licensing before the end of the year.

Daily weight loss pill helps patients lose 12% of body weight
BBC·United KingdomUnited Kingdom· 2025-08-08
7.0

Kenneth Custer, the president of Eli Lilly, discussed the potential of orforglipron in transforming obesity care.

Daily pill helps patients lose 12% of body weight in early trial | Diets and dieting
The Guardian·United KingdomUnited Kingdom· 2025-08-07
8.0
Also mentioned
Simon Cork
Simon Cork